|
|
||||||||
Department of Veterans Affairs, Western New York Health Care System, and Departments of Medicine and Physiology, University at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York 14214
| |
ABSTRACT |
|---|
|
|
|---|
We sought to identify mechanisms for chronic
dysfunction in hibernating myocardium. Pigs were instrumented with a
left anterior descending artery stenosis for 3 mo. Angiography
demonstrated high-grade stenoses and hibernating myocardium with
1) severe anterior hypokinesis
(P < 0.001 vs. shams),
2) reduced subendocardial perfusion
[0.73 ± 0.05 (SE) vs. 1.01 ± 0.06 ml · min
1 · g
1
in normal, P < 0.001], and
3) critically reduced adenosine flow (1.0 ± 0.17 vs. 3.84 ± 0.26 ml · min
1 · g
1
in normal, P < 0.001). Histology did
not reveal necrosis. Northern blot analysis of hibernating myocardium
demonstrated regional downregulation in mRNAs for sarcoplasmic
reticulum (SR) proteins phospholamban (0.76 ± 0.08 vs. 1.07 ± 0.06, P < 0.02) and SR
Ca2+-ATPase (0.83 ± 0.06 vs.
1.02 ± 0.06, P < 0.05)
with no change in calsequestrin (1.08 ± 0.06 vs. 0.96 ± 0.05, P = not significant). Heat shock protein (HSP)-70 mRNA was regionally induced in hibernating myocardium (2.4 ± 0.3 vs. 1.0 ± 0.11, P < 0.01). Directionally similar
changes were confirmed by Western blot analysis of respective proteins.
Our results indicate that hibernating myocardium exhibits a molecular
phenotype that on a regional basis is similar to end-stage ischemic
cardiomyopathy. This supports the hypothesis that SR dysfunction from
reversible ischemia may be an early defect in the progression
of left ventricular dysfunction.
coronary flow; myocardial ischemia; calcium regulatory proteins; sarcoplasmic reticulum
| |
INTRODUCTION |
|---|
|
|
|---|
ALTHOUGH ISCHEMIC cardiomyopathy is the leading etiological cause of congestive heart failure (15), the mechanisms through which chronic coronary artery disease progresses to decompensated left ventricular dysfunction are complex and poorly understood (33). Severe coronary artery disease and a history of symptomatic ischemia are present in the majority of patients, but the role of reduced coronary flow reserve in the progression of contractile dysfunction has not been resolved. Heart failure in coronary disease can arise from structural alterations consisting of myocyte necrosis and replacement fibrosis (3, 38), but contractile dysfunction due to abnormalities of intracellular calcium and alterations in myocyte function have also been implicated to play an important role (31). Explanted hearts from patients with advanced ischemic cardiomyopathy have reductions in the expression of some, but not all, of the sarcoplasmic reticulum (SR) calcium handling proteins (29), and in vitro studies demonstrate attenuated force-interval relationships in explanted cardiac muscle (34). This suggests that the contractile abnormalities may be due to SR dysfunction. Nevertheless, whether SR dysfunction arises secondary to global systemic hemodynamic changes or neurohormonal activation associated with advanced heart failure, or from repetitive myocardial ischemia due to extensive coronary artery disease has not been studied because it is difficult to dissociate these factors clinically or in experimental animal models of heart failure.
Chronically dysfunctional myocardium that is viable or "hibernating" is frequently found in patients with severe coronary artery disease and collateral-dependent myocardium (2, 45). Although this can occur in the absence of heart failure, it can also contribute to the progression of left ventricular dysfunction to clinical heart failure (15). The mechanisms responsible for chronic contractile dysfunction in hibernating myocardium are unclear, as are their relation to global alterations in advanced ischemic cardiomyopathy. One possibility is that the chronic alterations in SR proteins found in advanced heart failure are actually an early abnormality secondary to an intrinsic myocardial adaptation from intermittent ischemia. This may precede the development of structural fibrosis, neurohormonal activation, and global systemic abnormalities found in end-stage heart failure.
To test this hypothesis, we used a recently developed porcine model of regional, viable, dysfunctional myocardium that has all of the features of hibernating myocardium in humans, including regional reductions in resting flow and function and increased 18F-2-deoxyglucose uptake (12). The direct effects of a chronic reduction in regional coronary flow reserve could be studied because these animals do not develop systemic changes seen in heart failure. Our first aim was to study whether there was a regional downregulation in selected SR proteins that was similar to heart failure and to determine how this is related to coronary physiology in the intact animal. The second aim was to examine whether a chronic stenosis could be associated with the induction of mechanisms that protected myocytes from ischemia. To do this, we initially chose to examine heat shock protein (HSP)-70 that has been shown to be induced following brief total coronary occlusions and associated with protection against stunning and infarction (27, 43). The results indicate that hibernating myocardium exhibits a molecular phenotype that, while regional, is similar to global changes in ischemic cardiomyopathy. Thus SR dysfunction due to reversible ischemia may occur as an early defect in the progression of left ventricular dysfunction that precedes the development of the structural abnormalities seen in ischemic cardiomyopathy.
| |
METHODS |
|---|
|
|
|---|
All experimental procedures and protocols conformed to Institutional Guidelines for the Care and Use of Animals in Research. Studies were conducted in 24 hibernating animals that had a proximal left anterior descending artery (LAD) occlusion and 13 sham-instrumented controls. Terminal hemodynamic and coronary flow studies were performed in 22 hibernating animals (4 used for protein analysis and 18 used for RNA assessment) and 11 sham controls. The remaining four animals (2 hibernating and 2 sham) were killed without physiological studies to confirm that acute instrumentation had no affect on mRNA levels.
Chronic surgical preparation. The surgical preparation has been previously described (12). Briefly, juvenile pigs were fasted overnight, premedicated with a Telazol (50 mg/ml tiletamine and 50 mg/ml zolazepam)-ketamine (100 mg/ml) mixture (0.037 ml/kg im), and given prophylactic antibiotics (50 mg/kg iv cephalothin and 5 mg/kg im gentamicin). After endotracheal intubation a surgical plane of anesthesia was maintained with a halothane (0.5-2%) and oxygen (balance) mixture. A thoracotomy was performed in the fourth left intercostal space, and the proximal LAD was dissected free and instrumented with a Delran occluder [average ID 1.7 ± 0.1 (SE) mm]. In hibernating animals, the artery was secured within the occluder by a silk ligature or umbilical tape. In sham animals, the groove of the occluder was left open to circumvent the formation of a significant stenosis. After surgery was complete, the chest incision was closed in layers, the intercostal nerves were infiltrated with 2% lidocaine for analgesia, and the pneumothorax was evacuated. A postoperative dose of antibiotics was repeated, and an analgesic (0.025 mg/kg im butorphanol) was given and repeated as required to alleviate pain. Animals were fully recovered within 24 h. They were group housed and fed a diet of Pro-Lean (Agway, Akron, NY) ad libitum.
Hemodynamic studies in hibernating and sham-instrumented animals. Animals were brought back to the laboratory for physiological studies and tissue harvesting after ~3-4 mo. They were fasted overnight, and anesthesia was induced with a Telazol-xylazine (100 mg/ml) mixture (0.022 ml/kg im). After tracheal intubation, a surgical plane of anesthesia was maintained using a halothane (0.5-2%) and oxygen (balance) mixture supplemented with intramuscular doses of Telazol-xylazine (0.011 ml/kg) as required. The left carotid artery was instrumented with a 7-Fr introducer for coronary angiography. The right femoral artery was dissected free and used to pass an 8-Fr pigtail catheter retrogradely into the left ventricle using fluoroscopic guidance. A short catheter was placed into the left femoral artery to withdraw blood for microspheres using the reference sampling technique. Catheters were placed in the femoral veins to administer fluids (normal saline) and pharmacological agents. The animals were heparinized (10,000 U iv), and hemodynamics were allowed to equilibrate for at least 30 min before the protocol was begun.
After equilibration, colored microspheres were injected into the left ventricle to assess regional perfusion under resting conditions followed by contrast left ventriculography with hand injections of 10-20 ml of iohexol (Winthrop Pharmaceuticals, New York, NY). After resting measurements, an infusion of epinephrine was started and titrated so that heart rate increased to ~120-140 beats/min (0.27 ± 0.03 µg · kg
1 · min
1
iv). Once hemodynamics reached a steady state (~10 min), a second microsphere flow measurement was performed followed by a left ventriculogram. After the epinephrine was stopped and hemodynamics returned to baseline, pharmacological vasodilation was produced to
assess regional coronary flow reserve using intravenous adenosine (0.9 mg · kg
1 · min
1
iv). Because this dose of adenosine was accompanied by arterial hypotension without a reflex tachycardia in pigs, a simultaneous infusion of phenylephrine (5.5 ± 0.6 µg · kg
1 · min
1
iv) was started and titrated to restore systolic blood pressure to
control levels. After the protocol was completed, selective coronary
angiography was performed as previously described (12).
After angiography, the animals were deeply anesthetized and the heart
was rapidly excised and weighed. Samples from the anterior freewall and
septum that were immediately adjacent to the LAD and approximately
midway between the occluder and apex were taken for microsphere flow
analysis (duplicate samples) and RNA or protein isolation. Similar
samples were taken from the normal region midway between the base and
apex at the junction of the posterior freewall and septum. Our previous
studies demonstrated that these regions systematically represented
tissue from the central regions of LAD and normally perfused
myocardium. All samples were cut into three transmural layers of
approximately equal thickness. Samples for RNA isolation were handled
with precautions to prevent RNA degradation, flash frozen in liquid
nitrogen, and stored at
80°C until analyzed.
Microsphere flow and angiographic measurements. Regional perfusion was assessed with colored microspheres (15- µm diameter, Dye-Trak, Triton, San Diego, CA) using previously published techniques (12). Briefly, microspheres suspended in saline with thimerosal (0.01%) and Tween 80 (0.01%) were sonicated and vortex agitated before withdrawal. Approximately 3-5 million microspheres (yellow, red, white, or blue) were administered as a left ventricular bolus after an arterial reference sample was started from the femoral artery. At the end of the study, myocardial samples were weighed, digested in 4 M KOH with 2% Tween 80, and processed using previously published techniques (20). The dyes were eluted from the microspheres using a measured volume of dimethylformamide and aliquots placed in a multiple wavelength spectrophotometer (model U-2000, Hitachi, Tokyo, Japan). Absorbance was measured at the principal absorbance peak of each pure color dye and corrected for overlapping spectra using a matrix inversion technique (18, 20). Regional myocardial perfusion was calculated using the absorbance and flow rate of the arterial reference sample and myocardial absorbance per unit sample weight (20).
Magnified coronary angiograms were used to quantify the percent stenosis. End-systolic and end-diastolic images of the left ventricle were traced by two observers. Global ejection fraction was calculated from digitized tracings using the area length method (37), and the measurements from each observer were averaged. Regional wall motion in the anteroapical wall was assessed using the following scoring system: 3, normal; 2, mild hypokinesis; 1, severe hypokinesis; and 0, akinesis. Dyskinesis was not present under any condition. Ventriculography could not be performed in three animals from the hibernating group, and coronary angiography could not be completed in five animals from the hibernating group due to technical limitations.RNA isolation and Northern blot analysis.
Total myocardial RNA was isolated from subendocardial samples (inner
one-third) of the central LAD and normal remote regions by guanidinium
thiocyanate-phenol chloroform extraction (9). Because large variations
in HSP-70 expression were found, we also examined its distribution in
mid- and subepicardial samples. We simultaneously electrophoresed
20-µg aliquots of RNA on 0.8% agarose formaldehyde gels. These were
vacuum transferred onto nylon membranes and baked in a vacuum oven at
80°C. We hybridized Northern blots with a 2.3-kb probe for human
HSP-70 (47) [American Type Culture Collection (ATCC), Rockville,
MD]. Control for RNA loading was confirmed and quantified using a
1.2-kb probe to glyceraldehyde-3-phosphate dehydrogenase (GAPDH; ATCC)
(44). The remaining probes for
Ca2+-ATPase, calsequestrin,
calmodulin, phospholamban,
-myosin heavy chain, and the ryanodine
receptor were synthesized by PCR. First-strand cDNA was synthesized by
reverse transcribing myocardial mRNA with M-MLV Reverse Transcriptase
at 37°C for 1 h. This was subsequently amplified by PCR using
primers for the specific nucleotide sequence coding for each protein.
After an initial denaturation for 5 min at 94°C, samples were
cycled 25 times at 94°C for 30 s, at 45°C for 1 min, and at
72°C for 1 min. This was followed by a final 7-min extension at
72°C. The following pairs of oligonucleotide primers were used to
amplify probes from porcine myocardial cDNA with the exception of SR
Ca2+-ATPase, for which rat
myocardial cDNA was used: 1) rat SR
Ca2+-ATPase (24), sense primer
5'-TTGGCTTGGTTCGAAGAAGG-3' (+223 to +242 nt) and antisense
primer 5'-CCAAGAGCCACCATGAACTG-3' (+864 to +845 nt) to
produce a 642-bp fragment; 2)
calsequestrin (40), sense primer 5'-AAGCTTGCCAAGAAGCTGGG-3'
(+301 to +320 nt) and antisense primer
5'-GCAAAGGCCACAATGTGGAT-3' (+821 to +802 nt) to yield a
521-bp product; 3) calmodulin (13),
sense primer 5'-AGGAGTTGGGGACAGTGATG-3' (+192 to +211 nt)
and antisense primer 5'-ATGTCAGCCTCCCTGATCAT-3' (+492 to
+473 nt) to produce a 301-bp segment;
4) phospholamban (46), sense primer
5'-TCAGCTTTCTCTTGACGGCT-3' (
52 to
33 nt) and
antisense primer 5'-ACCCCTAGTTCATCCTCAGA-3' (+474 to +455
nt) to produce a 526-bp fragment; 5)
-myosin heavy chain (21), sense primer
5'-TGAAGGAGAACATCGCCATC-3' (+788 to +807 nt) and antisense
primer 5'-GTAGGTGAGCTCCTTGATGC-3' (+1344 to +1325 nt) to
yield a 557-bp product; and 6) the
cardiac ryanodine receptor (RYR2) (22), sense primer
5'-GGAAATCCATTCTGAATTCT-3' (+21 to +40 nt) and antisense
primer 5'-GCAGTCACAAACGGCTCGGT-3' (+488 to +507 nt) to
produce a 487-bp segment. The amplified cDNA products were inserted
into a vector [PCR-TRAP kit from GenHunter (Boston, MA) or TA
Cloning kit from Invitrogen (San Diego, CA)] and transformed into
Escherichia coli. HSP-70 and GAPDH
probes were labeled by random priming. All other probes were labeled by
PCR in the presence of
[
-32P]dCTP (30 cycles at 94°C, 30 s; 50°C, 1 min; 72°C, 1 min).
Protein isolation and Western blot analysis.
To confirm that mRNA alterations reflected steady-state changes in
protein levels, subendocardial samples were obtained from four animals
with regional reductions in resting perfusion that underwent identical
instrumentation. Protein was isolated from flash-frozen samples using
an extraction buffer containing 20 mM Tris (pH 7.4), 50 mM NaCl, 1 mM
EDTA (pH 8), 1 µg/ml pepstatin, 0.5 µg/ml leupeptin, 5 mM
-mercaptoethanol, 0.2 mM sodium vanadate, 10% SDS, and 0.2 mM
phenylmethylsulfonyl fluoride. Protein concentration for each sample
was measured in triplicate using the Lowry method (25). Aliquots of
protein (50 µg/lane for SR
Ca2+-ATPase, 75 µg/lane
calsequestrin and phospholamban, and 80 µg/lane for HSP-70) were
electrophoresed and separated on 10 or 14% SDS-polyacrylamide gels.
They were transferred to a nitrocellulose membrane (HSP-70, Protran,
Schleicher and Schuell, Keene, NH) or a polyvinylidene difluoride
membrane (other proteins, Immobilon-P, Millipore, Bedford, MA) and
blocked in 3% nonfat dry milk in PBS. After the membrane was rinsed,
it was incubated overnight with the primary antibody [SR
Ca2+-ATPase anti-canine mouse
monoclonal antibody (32), 1:1,500 dilution (MA3-919, Affinity
Bioreagents, Golden, CO)]; phospholamban anti-canine mouse
monoclonal antibody, 1:1,000 dilution (05-205, Upstate
Biotechnology, Lake Placid, NY); calsequestrin anti-canine rabbit
polyclonal antibody, 1:800 dilution (06-382, Upstate
Biotechnology); and HSP-70 anti-human mouse monoclonal antibody, which
recognizes both the constitutive (73 kDa) and inducible (72 kDa) forms
of HSP-70, 1:5,000 dilution (SPA-820, Stress Gen Biotechnology,
Victoria, BC). After being rinsed in PBS, membranes were incubated with peroxidase-labeled goat antibodies to IgG. Bands were visualized with
3,3',5,5'-tetramethylbenzidine (TMB) membrane peroxidase substrate (Kirkegaard and Perry, Gaithersburg, MD) and quantified on a
Laser Densitometer (Bio-Rad, Melville, NY). Linearity of density and protein loading for the SR
Ca2+-ATPase was demonstrated over
a range of 20-60 mg of total protein, between 25 and 100 mg of
total protein for phospholamban, and between 40 and 140 mg total
protein for calsequestrin and HSP-70.
Histology. Myocardial samples adjacent to those taken for RNA and protein analyses were immersed in Z-fix (Anatech, Battle Creek, MI). Thin sections were stained with Masson's trichrome stain to delineate connective tissue and fibroblast staining from normal myocytes. Percent connective tissue staining was quantified with standard point counting techniques using a 121-point grid at a magnification of ×200 as we have previously described (12). Two full-thickness regions were analyzed in each sample and selected to represent the area of greatest and least connective tissue staining in the sample. At least 30 fields were quantified and averaged for each sample. Connective tissue staining was expressed as a percentage of the total. Perivascular connective tissue staining and endocardial staining were included in the reported results.
Data analysis. All data are presented as means ± SE. Differences between sham and hibernating animals were determined using group t-tests for similar parameters and interventions. Measurements in the LAD region were compared with corresponding measurements in the normal region using paired t-tests. Differences between rest and pharmacological interventions were assessed using an ANOVA followed by paired t-tests and the Bonferroni correction for multiple comparisons. P < 0.05 level was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Myocardial perfusion and hemodynamics in hibernating versus sham
controls.
All animals were in good health at the time of study. Data for the
entire hibernating group (n = 22) are
summarized below. Body weight increased from 9.2 ± 0.4 kg at the
time of instrumentation to 83.0 ± 3.4 kg at the time of study
(average growth interval 102 ± 3 days). Left ventricular mass
averaged 217 ± 9 g, and mass-to-body weight ratio averaged 2.63 ± 0.07 g/kg. Arterial blood gases immediately before resting
measurements of myocardial perfusion averaged pH 7.40 ± 0.01, PCO2 38 ± 1 mmHg, and
PO2 477 ± 28 mmHg. Hematocrit
averaged 33 ± 1%. Under resting conditions, heart rate averaged 83 ± 3 beats/min, and systolic blood pressure averaged 121 ± 4 mmHg. Resting subendocardial perfusion averaged 0.73 ± 0.05 ml · min
1 · g
1
in LAD regions and 1.01 ± 0.06 ml · min
1 · g
1
in normal remote regions (P < 0.001). Corresponding full-thickness values were 0.80 ± 0.05 and 0.92 ± 0.06 ml · min
1 · g
1
(P < 0.001). During adenosine
vasodilation, subendocardial flow in the LAD region did not increase
significantly over rest values [1.0 ± 0.17 ml · min
1 · g
1,
P = not significant (ns) vs.
rest], but in normal remote regions it increased to 3.84 ± 0.26 ml · min
1 · g
1
(P < 0.001 vs. rest). Corresponding
full thickness values were 1.42 ± 0.16 ml · min
1 · g
1
in the LAD region (P < 0.01 vs.
rest) and 4.33 ± 0.24 ml · min
1 · g
1
in the remote normal zone (P < 0.001 vs. rest).
|
1 · g
1),
whereas there was no regional variation in sham-instrumented controls.
|
|
Alterations in SR
Ca2+-ATPase and
phospholamban mRNA in hibernating myocardium.
Figure 2 is a representative Northern blot
for paired samples from four hearts comparing mRNA levels in
dysfunctional hibernating regions with their corresponding expression
in normal remote regions from the same heart. Figure 3
summarizes the results of representative SR mRNAs from paired samples
from all of the hibernating animals that were studied. Data were
normalized to the GAPDH expression in each sample, which did not vary
between regions (subendocardial GAPDH 2.96 ± 0.23 densitometric
units in hibernating LAD regions versus 3.03 ± 0.24 densitometric
units in normal remote regions, P = ns). Although there was variability among animals, we found highly
significant reductions in the level of mRNA for phospholamban and the
SR Ca2+-ATPase in hibernating LAD
regions compared with normal regions, whereas mRNA for the SR calcium
binding protein calsequestrin was unchanged. The relative changes in
mRNA (LAD/normal) were also reduced in comparison to sham-instrumented
controls as summarized in Fig. 4 (phospholamban 0.76 ± 0.08 in hibernating vs. 1.07 ± 0.06 in shams,
P < 0.02; SR
Ca2+-ATPase 0.83 ± 0.06 in
hibernating vs. 1.02 ± 0.06 in shams,
P < 0.05; calsequestrin 1.08 ± 0.06 in hibernating vs. 0.96 ± 0.05 in shams,
P = ns). Analysis of the ryanodine
receptor mRNA was performed only in hibernating animals. The expression
of RYR2 relative to GAPDH was reduced in hibernating compared with
normal remote regions (LAD RYR2/GAPDH 0.12 ± 0.01 vs. 0.15 ± 0.01 in normal regions, n = 17, P < 0.05; LAD/normal 0.85 ± 0.07). These data indicate that there were significant reductions in
the mRNAs for the SR calcium uptake and release proteins, whereas the
constancy of mRNA for calsequestrin suggests that this did not reflect
a nonspecific alteration in the expression of all SR proteins.
|
|
|
Transmural induction of HSP-70 mRNA in hibernating animals.
We found a graded induction of mRNA for HSP-70 across the wall of the
LAD region of hibernating animals. Figure
5 depicts the
results of a representative gel from an individual animal with
hibernating myocardium. There was a low uniform HSP-70 mRNA expression
in all layers of the normally perfused region that was similar to that
seen in sham-instrumented animals. In contrast, there was an induction
of HSP-70 mRNA in hibernating LAD regions that was greatest in the
subendocardium and least in the subepicardium. Figure
6 compares the induction of HSP-70 mRNA
relative to GAPDH in the LAD region of hibernating animals versus
sham-instrumented controls. HSP-70 levels were uniform in all
transmural layers of the normally perfused regions as well as in the
LAD region in shams. In contrast, there was a greater than twofold
induction of HSP-70 mRNA in the subendocardium of hibernating hearts,
which decreased toward the subepicardium
(P < 0.05 vs. each corresponding layer in the normal region). Figure 7
summarizes the results of subendocardial HSP-70 mRNA in comparison to
mRNA levels of the cytosolic proteins calmodulin and
-myosin heavy
chain. The levels of HSP-70 mRNA were increased in hibernating compared
with sham animals. There was no regional induction of calmodulin and
-myosin heavy chain mRNA in the LAD region of hibernating animals
relative to normal remote regions. Whereas sham-instrumented animals
showed no regional difference in mRNA for HSP-70 or calmodulin, there was a slight but significant increase in the expression of
-myosin heavy chain that was secondary to increased levels in the LAD zones of
sham-instrumented animals.
|
|
|
Alterations of candidate proteins in hibernating myocardium.
Figure 8 and Table 3 summarize the
Western blot analysis for SR
Ca2+-ATPase, calsequestrin,
phospholamban, and HSP-70 protein from four hibernating animals.
Subgroup analysis showed no differences in resting or vasodilated flow
compared with the group used for mRNA measurements. In comparison to
normally perfused remote myocardium, hibernating regions had
significantly lower protein levels of SR
Ca2+-ATPase and phospholamban but
no significant change in calsequestrin. Immunoblots for HSP-70 in
hibernating regions revealed two bands consistent with the constitutive
(73 kDa) and inducible (72 kDa) forms. Although densitometric analysis
revealed significant increases in both forms, induction was most
evident in the 72-kDa band with a twofold increase. Thus the
quantitation of candidate proteins confirmed directionally similar
changes as seen for the mRNA.
|
|
Relation of SR gene expression to regional adenosine flow reserve.
Figure 9 highlights the relation between relative
adenosine flow (LAD/normal) and mRNA changes for selected SR proteins.
A novel observation was that the magnitude of mRNA changes in
dysfunctional LAD regions correlated with the physiological
significance of the stenosis or collateral vasodilator reserve.
Sham-instrumented animals showed no relation between mRNA and relative
flow during adenosine. In contrast, the expression of phospholamban and
the SR Ca2+-ATPase mRNA were
significantly correlated with the severity of flow reserve reduction.
At modest levels of flow impairment, there appeared to be little
systematic change in mRNA despite the fact that myocardial function was
chronically depressed. When flow reserve was more severely reduced,
there was a reduction in SR Ca2+-ATPase and phospholamban
mRNA. Calsequestrin expression was unchanged over a wide range of
stenosis severity. These results suggest that the molecular adaptations
seen in hibernating myocardium are likely related to repetitive
ischemia that will increase in frequency and severity as
adenosine flow reserve is reduced.
|
| |
DISCUSSION |
|---|
|
|
|---|
There are two important new findings from our study. First, pigs with hibernating myocardium develop regional alterations in the expression of the SR calcium uptake proteins phospholamban and Ca2+-ATPase, which may be one of the mechanisms responsible for producing resting regional dysfunction. Western analysis confirmed that the regional alterations in mRNA were associated with regional changes in protein content. Whereas the pattern of expression we found was similar to that reported in cardiomyopathy and decompensated left ventricular hypertrophy, the changes were regional and occurred without global alterations in hemodynamics compared with sham control animals, indicating that they arise from chronic intermittent myocardial ischemia. Second, we found a regional induction of stress protein HSP-70 with increases in both the 72- and 73-kDa proteins by Western blot analysis. To our knowledge, this is the first demonstration that chronic reversible subendocardial ischemia can alter myocyte phenotype on a regional basis.
Downregulation in expression of selected SR proteins in hibernating
myocardium.
The results of our study indicate that the SR proteins involved in the
uptake and release of calcium, the SR
Ca2+-ATPase, phospholamban, and
the ryanodine receptor are coordinately downregulated in our porcine
model of hibernating myocardium. The changes were restricted to the
dysfunctional LAD region and did not appear to be related to a
generalized reduction in the SR proteins or a loss of SR within
myocytes because mRNA and protein levels for the SR calcium binding
protein calsequestrin remained unchanged. They also appear unrelated to
myocyte loss because mRNA levels for cytosolic proteins such as GAPDH,
calmodulin, and
-myosin heavy chain were not significantly reduced
in hibernating myocardium. Histological samples showed no myocardial
necrosis, and point counting showed only a small increase in connective tissue staining in the hibernating regions, similar to that reported in
patients with collateral-dependent myocardium distal to chronic LAD
occlusions and clinically documented hibernating myocardium (5). These
changes were much less extensive than those reported by Elsässer
et al. (10) where up to 58% of the wall was fibrotic in reversibly
dyssynergic myocardium, indicating that our findings may be
representative of an earlier stage of disease. Thus the selective
reduction in the expression of SR calcium uptake and release proteins
supports the hypothesis that the chronic contractile abnormalities
found in hibernating myocardium are secondary to SR dysfunction and
arise from chronic intermittent ischemia. This precedes the
advanced structural changes that could affect contractile function in
an independent fashion.
-myosin heavy chain, suggesting an even more generalized pattern
of injury-repair following repetitive total occlusions (19). In
contrast, Abraham et al. (1) recently found no change in mRNA levels
for SR calcium regulatory proteins in stunned myocardium following
partial coronary occlusion, indicating that the effects of acute
ischemia on transcription may depend on the severity of flow
reduction. Other laboratories have demonstrated that phospholamban and
the SR Ca2+-ATPase protein levels
are unaltered following acute ischemia (26, 42). Thus the
findings in acutely dysfunctional, stunned myocardium are in sharp
contrast with the pattern of downregulation that we found in chronic
hibernating myocardium, indicating that the contractile dysfunction is
probably not simply a reflection of acute stunning that has not had
time to fully recover.
Interestingly, the regional mRNA and protein changes we found in
hibernating myocardium are similar to the global reductions in
expression of the SR Ca2+-ATPase
and phospholamban found in explanted hearts from patients with
end-stage congestive heart failure (29, 30). The ryanodine receptor has
also been found to be downregulated in ischemic but not idiopathic
dilated cardiomyopathy (7). Variability has been found regarding
corresponding changes in protein levels in advanced heart failure with
some studies showing them to be reduced (30), whereas others show them
to be unchanged (32, 39); these have recently been reviewed (16).
We found significant reductions in mRNA and protein levels for the SR
Ca2+-ATPase and phospholamban with
no change in calsequestrin in hibernating myocardium. These were
inversely related to coronary flow reserve and thus the propensity of a
region to develop ischemia. They did not appear to be the
result of reduced resting flow since we have recently reported regional
reductions in SR Ca2+-ATPase and
phospholamban in chronically stunned pigs that were studied 1 and 2 mo
after placement of an LAD stenosis (23). At this time animals had
depressed function and reduced LAD flow reserve with normal resting
perfusion (11). Thus the reduction in selected SR protein expressions
support the induction of a chronic adaptive response that develops in
relation to the physiological severity of a coronary stenosis.
Although acute inotropic stimulation improves myocardial function in
hibernating myocardium, the net effect is a complex interplay between
the cellular mechanisms responsible for chronic contractile dysfunction
and superimposed acute demand-induced ischemia. The relative
importance of altered myocyte function versus limited flow reserve in
the inotropic response will require additional studies where regional
metabolism can be quantified simultaneously. The regional reductions in
SR proteins found in hibernating myocardium where coronary flow reserve
is critically impaired may serve as an adaptive role because they could
lead to a regional attenuation of rate-related increases in myocardial
oxygen consumption during tachycardia vis-a-vis an altered force
frequency relation (17, 34). This could minimize regional imbalances
between myocardial oxygen supply and demand in a hibernating region
during stress. Although speculative, our data in hibernating myocardium
without heart failure raise the possibility that SR dysfunction may be a common and early abnormality in the evolution of ischemic
cardiomyopathy that is potentially reversible before the onset of
structural fibrosis.
Transmural induction of HSP-70 distal to chronic stenosis. We also found that the stress protein HSP-70 was variably increased in hibernating myocardium. The magnitude of HSP-70 mRNA induction was most pronounced in the subendocardial layers. Previous studies have demonstrated that HSP-70 can be induced after repetitive brief total coronary occlusions in pigs and that this is associated with accelerated recovery of myocardial function when a series of brief occlusions is performed 24 h later (preconditioning against myocardial stunning) (43). Other studies have demonstrated a small, statistically insignificant reduction in infarct size in pigs following prolonged occlusions when a repetitive ischemic stimulus is performed 24 h earlier (second window of preconditioning)(35). Despite these experimental findings, the relevance of this endogenous protective mechanism in chronic coronary artery disease is uncertain since ischemia produced by brief repetitive total coronary occlusions is somewhat artificial and, aside from unstable coronary syndromes, unlikely to mimic clinical circumstances in which the myocardium will be subjected to demand-induced ischemia.
Our study extends these earlier observations by demonstrating that HSP-70 can be chronically induced distal to a severe coronary stenosis or in collateral-dependent myocardium. Nevertheless, induction of HSP-70 required a severe reduction in coronary flow reserve. Western blot analysis revealed a small (10%) but significant increase in the constitutive 73-kDa form and a twofold increase in the inducible 72-kDa isoform. Variability in HSP-70 expression appears importantly related to the physiological significance of the chronic coronary stenosis in this model of hibernating myocardium. In the subendocardium, where coronary flow during adenosine was critically reduced, HSP-70 mRNA was more than two times greater than normal regions. Even though maximal flow was also severely restricted in subepicardial hibernating LAD regions, the level of HSP-70 induction was considerably lower (1.3 times normal). Thus the chronic induction of HSP-70 appears to require a physiologically severe reduction in coronary flow reserve and may not be spontaneously induced in the majority of patients with moderate chronic coronary disease in which resting contractile function is normal.Methodological limitations. We assessed regional wall motion with left ventriculography to circumvent potential nonspecific effects of instrumentation on inducing mRNA (6). Because the relation between regional perfusion and radial wall motion has not been established, we could not ascertain the extent to which chronic recurrent myocardial stunning (which would be associated with a dissociation between subendocardial flow and the degree of dysfunction) could have contributed to the chronic dysfunction. Nevertheless, stunning alone cannot explain our observations since it is associated with normal rather than reduced values of resting perfusion (4, 8, 36, 41). In pigs studied at 1 and 2 mo after instrumentation we have found viable dysfunctional myocardium without a reduction in resting flow (11). These data along with the present findings are consonant with the notion that there is a temporal transition from chronic stunning with normal flow to hibernation with depressed resting flow during the progression of a chronic stenosis, as we previously reported in dogs (8).
The presence of recruitable inotropic reserve in response to catecholamine infusion, the regional increase in 18F-2-deoxyglucose uptake with a mismatch pattern similar to humans (28) in our previous study (12), and the lack of pathological necrosis all substantiate that the dysfunctional LAD regions were viable. The molecular alterations in hibernating myocardium would support the notion that this involves cellular remodeling and may take considerably longer than the hours to days over which stunning improves. Further studies will be required to examine the time course of improvement following the restoration of blood flow in this model. In summary, although the physiological implications of reduced expression of selected SR proteins and increased expression of HSP-70 in hibernating myocardium remain to be established, the intriguing possibility exists that myocytes subjected to chronic reversible ischemia may be protected against the development of irreversible injury. Adaptations in SR gene expression could be responsible for the chronic alterations in regional mechanical function and reduce regional myocardial demand. In conjunction with known variables such as collateral flow and myocardial oxygen consumption at the time of ischemia, the induction of molecular adaptations that increase the tolerance of the heart to inadequate perfusion in chronic ischemic heart disease may be responsible for the beneficial effects of reperfusion as late as 12 h after a coronary occlusion. Further studies will be required to determine the physiological importance of these and other intrinsic myocardial adaptations in hibernating myocardium.| |
ACKNOWLEDGEMENTS |
|---|
We thank Deana Gretka, Amy Johnson, Felicia Bosinski, and Susan Fopeano for expert technical assistance throughout this study.
| |
FOOTNOTES |
|---|
This work was supported by a Clinician Scientist Award and Affiliate Grant-in-Aid from the American Heart Association; a Merit Review Award from the Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs; the Albert and Elizabeth Rekate Fund; and the National Heart, Lung, and Blood Institute Grant HL-55324. S. Jacob was supported by the John C. Sable Award from the New York State Independent Order of Odd Fellows.
Portions of this work were presented in part at the 1995 American Federation for Clinical Research Meeting (San Diego, CA), the 1995 Scientific Sessions of the American Heart Association (Anaheim, CA), and the 1997 Scientific Sessions of the American College of Cardiology (Anaheim, CA).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: J. M. Canty, Jr., Biomedical Research Bldg., Rm. 347, Div. of Cardiology, Dept. of Medicine, Univ. at Buffalo, 3435 Main St., Buffalo, NY 14214 (E-mail: canty{at}buffalo.edu).
Received 18 February 1999; accepted in final form 24 May 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abraham, S.,
R. F. Young,
and
J. M. Canty, Jr.
Post-ischemic dysfunction following short-term hibernation is not associated with increased mRNA for sarcoplasmic reticulum calcium regulatory proteins (Abstract).
Circulation
94, Suppl. I:
I-186,
1996.
2.
Arani, D. T.,
D. G. Greene,
I. L. Bunnell,
G. L. Smith,
and
F. J. Klocke.
Reductions in coronary flow under resting conditions in collateral-dependent myocardium of patients with complete occlusion of the left anterior descending coronary artery.
J. Am. Coll. Cardiol.
3:
668-674,
1984[Abstract].
3.
Beltrami, C. A.,
N. Finato,
M. Rocco,
G. A. Feruglio,
C. Puricelli,
E. Cigola,
F. Quaini,
E. H. Sonnenblick,
G. Olivetti,
and
P. Anversa.
Structural basis of end-stage failure in ischemic cardiomyopathy in humans.
Circulation
89:
151-163,
1994
4.
Bolli, R.
Myocardial "stunning" in man.
Circulation
86:
1671-1691,
1992
5.
Borgers, M.,
F. Thoné,
L. Wouters,
J. Ausma,
B. Shivalkar,
and
W. Flameng.
Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation?
Cardiovasc. Pathol.
2:
237-245,
1993.
6.
Brand, T.,
H. S. Sharma,
K. E. Fleischmann,
D. J. Duncker,
E. O. McFalls,
P. D. Verdouw,
and
W. Schaper.
Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion.
Circ. Res.
71:
1351-1360,
1992
7.
Brillantes, A.-M.,
P. Allen,
T. Takahashi,
S. Izumo,
and
A. R. Marks.
Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy.
Circ. Res.
71:
18-26,
1992
8.
Canty, J. M., Jr.,
and
F. J. Klocke.
Reductions in regional myocardial function at rest in conscious dogs with chronically reduced regional coronary artery pressure.
Circ. Res.
61, Suppl. II:
II-107-II-116,
1987.
9.
Chomczynski, P.,
and
N. Sacchi.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:
156-159,
1987[Medline].
10.
Elsässer, A.,
M. Schlepper,
W. P. Klövekorn,
W. Cai,
R. Zimmermann,
K. D. Müller,
R. Strasser,
S. Kostin,
C. Gagel,
B. Münkel,
W. Schaper,
and
J. Schaper.
Hibernating myocardium: an incomplete adaptation to ischemia.
Circulation
96:
2920-2931,
1997
11.
Fallavollita, J. A.,
and
J. M. Canty, Jr.
Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion.
Circulation
99:
2798-2805,
1999
12.
Fallavollita, J. A.,
B. J. Perry,
and
J. M. Canty, Jr.
18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium.
Circulation
95:
1900-1909,
1997
13.
Fischer, R.,
M. Koller,
M. Flura,
S. Mathews,
M.-A. Strehler-Page,
J. Krebs,
J. T. Penniston,
E. Carafoli,
and
E. E. Strehler.
Multiple divergent mRNAs code for a single human calmodulin.
J. Biol. Chem.
263:
17055-17062,
1988
14.
Frass, O.,
H. S. Sharma,
R. Knöll,
D. J. Duncker,
E. O. McFalls,
P. D. Verdouw,
and
W. Schaper.
Enhanced gene expression of calcium regulatory proteins in stunned porcine myocardium.
Cardiovasc. Res.
27:
2037-2043,
1993
15.
Gheorghiade, M.,
and
R. O. Bonow.
Chronic heart failure in the United States: a manifestation of coronary artery disease.
Circulation
97:
282-289,
1998
16.
Hasenfuss, G.,
M. Meyer,
W. Schillinger,
M. Preuss,
B. Pieske,
and
H. Just.
Calcium handling proteins in the failing human heart.
Basic Res. Cardiol.
92:
87-93,
1997.
17.
Hasenfuss, G.,
H. Reinecke,
R. Studer,
M. Meyer,
B. Pieske,
J. Holtz,
C. Holubarsch,
H. Posival,
H. Just,
and
H. Drexler.
Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium.
Circ. Res.
75:
434-442,
1994
18.
Heymann, M. A.,
B. D. Payne,
J. I. E. Hoffman,
and
A. M. Rudolph.
Blood flow measurements with radionuclide-labeled particles.
Prog. Cardiovasc. Dis.
20:
55-79,
1977[Medline].
19.
Knöll, R.,
M. Arras,
R. Zimmerman,
J. Schaper,
and
W. Schaper.
Changes in gene expression following short coronary occlusions studied in porcine hearts with run-on assays.
Cardiovasc. Res.
28:
1062-1069,
1994[Medline].
20.
Kowallik, P.,
R. Schulz,
B. D. Guth,
A. Schade,
W. Paffhausen,
R. Gross,
and
G. Heusch.
Measurement of regional myocardial blood flow with multiple colored microspheres.
Circulation
83:
974-982,
1991
21.
Kurabayashi, M.,
H. Tsuchimochi,
I. Komuro,
F. Takaku,
and
Y. Yazaki.
Molecular cloning and characterization of human cardiac
- and
-form myosin heavy chain complementary DNA clones: regulation of expression during development and pressure overload in human atrium.
J. Clin. Invest.
82:
524-531,
1988.
22.
Ledbetter, M. W.,
J. K. Preiner,
C. F. Louis,
and
J. R. Mickelson.
Tissue distribution of ryanodine receptor isoforms and alleles determined by reverse transcription polymerase chain reaction.
J. Biol. Chem.
269:
31544-31551,
1994
23.
Lim, H.,
J. A. Fallavollita,
and
J. M. Canty, Jr.
Myocyte apoptosis and downregulation of SR gene expression are inversely related to coronary flow and reserve and early events in the evolution of ischemic LV dysfunction (Abstract).
Circulation
98:
I-762,
1998.
24.
Lompre, A.-M.,
D. de la Bastie,
K. R. Boheler,
and
K. Schwartz.
Characterization and expression of the rat heart sarcoplasmic reticulum Ca2+-ATPase mRNA.
FEBS Lett.
249:
35-41,
1989[Medline].
25.
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr,
and
R. J. Randall.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:
265-275,
1951
26.
Lüss, H.,
P. Boknik,
G. Heusch,
F. U. Muller,
J. Neumann,
W. Schmitz,
and
R. Schulz.
Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart.
Cardiovasc. Res.
37:
606-617,
1998[Medline].
27.
Marber, M. S.,
D. S. Latchman,
J. M. Walker,
and
D. M. Yellon.
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.
Circulation
88:
1264-1272,
1993
28.
Mäki, M.,
M. Luotolahti,
P. Nuutila,
H. Iida,
L.-M. Voipio-Pulkki,
U. Ruotsalainen,
M. Haaparanta,
O. Solin,
J. Hartiala,
R. Härkönen,
and
J. Knuuti.
Glucose uptake in the chronically dysfunctional but viable myocardium.
Circulation
93:
1658-1666,
1996
29.
Mercadier, J.-J.,
A.-M. Lompré,
P. Duc,
K. R. Boheler,
J.-B. Fraysse,
C. Wisnewsky,
P. D. Allen,
M. Komajda,
and
K. Schwartz.
Altered sarcoplasmic reticulum Ca2+-ATPase gene expression in the human ventricle during end-stage heart failure.
J. Clin. Invest.
85:
305-309,
1990.
30.
Meyer, M.,
W. Schillinger,
B. Pieske,
C. Holubarsch,
C. Heilmann,
H. Posival,
G. Kuwajima,
K. Mikoshiba,
H. Just,
and
G. Hasenfuss.
Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy.
Circulation
92:
778-784,
1995
31.
Morgan, J. P.
Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction.
N. Engl. J. Med.
325:
625-632,
1991[Medline].
32.
Movsesian, M. A.,
M. Karimi,
K. Green,
and
L. R. Jones.
Ca2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium.
Circulation
90:
653-657,
1994
33.
Pantely, G. A.,
and
J. D. Bristow.
Ischemic cardiomyopathy.
Prog. Cardiovasc. Dis.
27:
95-114,
1984[Medline].
34.
Pieske, B.,
B. Kretschmann,
M. Meyer,
C. Holubarsch,
H. Weirich,
H. Posival,
K. Minami,
H. Just,
and
G. Hasenfuss.
Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy.
Circulation
92:
1169-1178,
1995
35.
Qiu, Y.,
X.-L. Tang,
S.-W. Park,
J.-Z. Sun,
A. Kalya,
and
R. Bolli.
The early and late phases of ischemic preconditioning. A comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion.
Circ. Res.
80:
730-742,
1997
36.
Ross, J., Jr.
Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation.
Circulation
83:
1076-1083,
1991
37.
Sandler, H.,
and
H. T. Dodge.
The use of single plane angiocardiograms for the calculation of left ventricular volume in man.
Am. Heart J.
75:
325-334,
1968[Medline].
38.
Schuster, E. H.,
and
B. H. Bulkley.
Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients.
Am. Heart J.
100:
506-512,
1980[Medline].
39.
Schwinger, R. H. G.,
M. Böhm,
U. Schmidt,
P. Karczewski,
U. Bavendiek,
M. Flesch,
E.-G. Krause,
and
E. Erdmann.
Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
Circulation
92:
3220-3228,
1995
40.
Scott, B. T.,
H. K. B. Simmerman,
J. H. Collings,
B. Nadal-Ginard,
and
L. R. Jones.
Complete amino acid sequence of canine cardiac calsequestrin deduced by cDNA cloning.
J. Biol. Chem.
263:
8958-8964,
1988
41.
Shen, Y.-T.,
and
S. F. Vatner.
Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: hibernation versus stunning?
Circ. Res.
76:
479-488,
1995
42.
Smart, S. C.,
K. B. Sagar,
J. el Schultz,
D. C. Warltier,
and
L. R. Jones.
Injury to the Ca2+-ATPase of the sarcoplasmic reticulum in anesthetized dogs contributes to myocardial reperfusion injury.
Cardiovasc. Res.
36:
174-184,
1997
43.
Sun, J.-Z.,
X.-L. Tang,
A. A. Knowlton,
S.-W. Park,
Y. Qiu,
and
R. Bolli.
Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs.
J. Clin. Invest.
95:
388-403,
1995.
44.
Tso, J. Y.,
X.-H. Sun,
T. Kao,
K. S. Reece,
and
R. Wu.
Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene.
Nucleic Acids Res.
13:
2485-2502,
1985
45.
Vanoverschelde, J.-L. J.,
W. Wijns,
C. Depré,
B. Essamri,
G. R. Heyndrickx,
M. Borgers,
A. Bol,
and
J. A. Melin.
Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium.
Circulation
87:
1513-1523,
1993
46.
Verboomen, H.,
F. Wuytack,
J. A. Eggermont,
S. de Jaegere,
L. Missiaen,
L. Raeymaekers,
and
R. Casteels.
cDNA cloning and sequencing of phospholamban from pig stomach smooth muscle.
Biochem. J.
262:
353-356,
1989[Medline].
47.
Wu, B.,
C. Hunt,
and
R. Morimoto.
Structure and expression of the human gene encoding major heat shock protein HSP70.
Mol. Cell. Biol.
5:
330-341,
1985
This article has been cited by other articles:
![]() |
S. Baldwa, M. Rana, J. M. Canty Jr., and J. A. Fallavollita Comparison of thallium deposition with segmental perfusion in pigs with chronic hibernating myocardium Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2522 - H2529. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls, R. F. Kelly, Q. Hu, A. Mansoor, J. Lee, M. Kuskowski, J. Sikora, H. B. Ward, and J. Zhang The energetic state within hibernating myocardium is normal during dobutamine despite inhibition of ATP-dependent potassium channel opening with glibenclamide Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2945 - H2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Banas, S. Baldwa, G. Suzuki, J. M. Canty Jr., and J. A. Fallavollita Determinants of contractile reserve in viable, chronically dysfunctional myocardium Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2791 - H2797. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fallavollita, B. J. Riegel, G. Suzuki, U. Valeti, and J. M. Canty Jr. Mechanism of sudden cardiac death in pigs with viable chronically dysfunctional myocardium and ischemic cardiomyopathy Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2688 - H2696. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ovchinnikov, G. Suzuki, J. M. Canty Jr., and J. A. Fallavollita Blunted functional responses to pre- and postjunctional sympathetic stimulation in hibernating myocardium Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1719 - H1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heusch, R. Schulz, and S. H. Rahimtoola Myocardial hibernation: a delicate balance Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H984 - H999. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Depre, S.-J. Kim, A. S. John, Y. Huang, O. E. Rimoldi, J. R. Pepper, G. D. Dreyfus, V. Gaussin, D. J. Pennell, D. E. Vatner, et al. Program of Cell Survival Underlying Human and Experimental Hibernating Myocardium Circ. Res., August 20, 2004; 95(4): 433 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, H. Post, T. Neumann, P. Gres, H. Luss, and G. Heusch Progressive loss of perfusion-contraction matching during sustained moderate ischemia in pigs Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1945 - H1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Dispersyn and M. Borgers Apoptosis in the Heart: About Programmed Cell Death and Survival Physiology, February 1, 2001; 16(1): 41 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Schulz and G Heusch Hibernating myocardium Heart, December 1, 2000; 84(6): 587 - 594. [Full Text] |
||||
![]() |
J. A. Fallavollita Spatial Heterogeneity in Fasting and Insulin-Stimulated 18F-2-Deoxyglucose Uptake in Pigs With Hibernating Myocardium Circulation, August 22, 2000; 102(8): 908 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fallavollita and J. M. Canty Jr. Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1370 - H1379. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |